Nick Tait
Director Financiero/CFO en Metrion Biosciences Ltd. .
Perfil
Nick Tait is the founder of The Great Little Pub Co. Ltd.
He is currently working as the Chief Financial Officer, Secretary & Director at Metrion Biosciences Ltd.
Cargos activos de Nick Tait
| Empresas | Cargo | Inicio |
|---|---|---|
Metrion Biosciences Ltd.
 Metrion Biosciences Ltd. BiotechnologyHealth Technology Metrion Biosciences Ltd. is a contract research organization that specializes in providing drug discovery services to pharmaceutical and bioscience customers. Metrion Biosciences is based in Great Abington, UK and was founded in 2015. The British company offers a range of high-quality ion channel assays on a fee-for-service or collaboration basis, including an industry-leading panel of in vitro cardiac ion channel safety assays, translational native cell and phenotypic assays for neurological and cardiotoxicity testing, and a range of other ion channel screening services such as cell line development and optimization. Andrew Southan has been the CEO of the company since 2016. | Director Financiero/CFO | - |
Antiguos cargos conocidos de Nick Tait.
| Empresas | Cargo | Fin |
|---|---|---|
The Great Little Pub Co. Ltd.
 The Great Little Pub Co. Ltd. RestaurantsConsumer Services The Great Little Pub Co. Ltd. owns and operates pubs and restaurants. The company was founded by Nick Tait and is headquartered in Brighton, the United Kingdom. | Fundador | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
The Great Little Pub Co. Ltd.
The Great Little Pub Co. Ltd. RestaurantsConsumer Services The Great Little Pub Co. Ltd. owns and operates pubs and restaurants. The company was founded by Nick Tait and is headquartered in Brighton, the United Kingdom. | Consumer Services |
Metrion Biosciences Ltd.
Metrion Biosciences Ltd. BiotechnologyHealth Technology Metrion Biosciences Ltd. is a contract research organization that specializes in providing drug discovery services to pharmaceutical and bioscience customers. Metrion Biosciences is based in Great Abington, UK and was founded in 2015. The British company offers a range of high-quality ion channel assays on a fee-for-service or collaboration basis, including an industry-leading panel of in vitro cardiac ion channel safety assays, translational native cell and phenotypic assays for neurological and cardiotoxicity testing, and a range of other ion channel screening services such as cell line development and optimization. Andrew Southan has been the CEO of the company since 2016. | Health Technology |
- Bolsa de valores
- Insiders
- Nick Tait
